Making a Business Case for PAT and QbD ImplementationHosted By : Andrea Charles
October 31, 2011
Brett Cooper | Merck | PAT | QbD | quality by design | PAT and QbD implementation | FDA | EMEA | QbD principles | process analytical technology
About this Podcast...
What are the 7 Deadly Sins of Quality Assurance and Quality Control?
Download our free QA QC eBook now to find out!
In this presentation Brett Cooper Research Fellow, MSD Development Laboratories, speaks to Andrea Charles from Pharma IQ, about the slower than anticipated industry uptake of PAT and QbD, the key benefits of PAT and QbD implementation and the biggest challenge pharma and bio companies face regarding the interpretation of regulatory guidance. Cooper also discusses how to prove the business case for PAT and QbD implementation.
Have Your Say
Rate this feature and give us your feedback in the comments section below
to get access to this White Paper
comments powered by Disqus
17th Software Design for Medial Devices
San Francisco, CA
May 19- 19, 2014
Medical Device UDIs & Traceability Forum
Le Méridien München, Munich, Germany
May 20- 22, 2014
3rd Annual Pharmaceutical Cold Chain India
Venue To Be Confirmed, Hyderabad, India
May 22- 23, 2014
LIMS and the Lab Informatics Landscape
April 10, 2014
Defining a Successful ELN Implementation Strategy
July 29, 2013